BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

CN Bio Innovations (Formerly known as Zyomyx, Inc.) 

6519 Dumbarton Circle

Fremont  California  94555  U.S.A.
Phone: 510-265-8000 Fax: 510-784-2569


SEARCH JOBS

Zyomyx, Inc. is a privately held diagnostics company based in Fremont, California -- a developer, manufacturer and marketer of innovative point-of-care diagnostic products.

Do you want to make a positive contribution to humanity -- one that significantly impacts the international community, a cause which engages heads of nations? Do you want to join an entrepreneurial and growing diagnostics company that functions with the electricity of a startup, but one that has stood the test of time? At Zyomyx, you get the best of both worlds!

We are on a powerful and important mission -- charting the course for not only improving quality of life, but contributing to saving millions of lives in countries around the world. Zyomyx has also attracted the attention of and entered into an exclusive distribution agreement with Mylan, global pharmaceutical giant with 10+ years’ presence in emerging markets, to distribute its revolutionary MyT4 POC CD4 diagnostic test for HIV/AIDs in the developing world. Mylan chose Zyomyx as its first entry into the diagnostics market to set new standards in health care, realizing that the MyT4 test provides “gold standard” accuracy, enables access for patients and cost effectiveness for national HIV programs, contributing a critical tool to reach the goal of universal access to treatment for the 28 million people living with HIV globally. Other benefits of this diagnostic test are ease of use, portability, and service-free configuration.

While Zyomyx focuses INITIALLY on this key core product, we also know that incredible future potential opportunities exist from our other various core technology platforms to bring complex lab diagnostics into POC, a growing and burgeoning worldwide market. As a result, the Company will launch follow-on products for launch in markets of high income countries over the coming years

Our culture represents innovative, driven and talented individuals bringing diverse perspectives, and one which is united on a mission to significantly and positively impact lives globally.


 Key Statistics


Email: info@zyomyx.com
Ownership: Private

Web Site: CN Bio Innovations
Employees: 70
Symbol: 
 



Industry
Medical Device






 Company News
3D Liver Model Expert Zyoxel Ltd To Become CN Bio Innovations 2/10/2014 9:42:25 AM    More...
Mylan Inc. (MYL) and Zyomyx, Inc. Enter into Exclusive Distribution Agreement for Innovative Point-of-Care CD4 Diagnostic Test, Enhancing Mylan's Leadership Position in HIV Care 7/1/2013 10:14:48 AM    More...
Zyomyx, Inc. Lands $12 Million to Enable Launch of Low-Cost, Rapid Point-of-Care CD4 Test 7/1/2013 6:42:37 AM    More...
Zyomyx, Inc. Receives ISO 13485: 2003 Certification 2/28/2013 10:27:34 AM    More...
Zyomyx, Inc. Announces Appointment of Chief Financial Officer 9/24/2012 9:29:12 AM    More...
Zyomyx, Inc. Awarded Grant from the CD4 Initiative at Imperial College London 3/8/2007 10:20:41 AM    More...
Invitrogen Corporation (IVGN) Licenses Key Protein Chip Intellectual Property From Zyomyx, Inc.; Broad Manufacturing Patents Strengthen Invitrogen's Position In Protein Microarrays 10/19/2005 5:12:20 PM    More...
Zyomyx, Inc. Names Peter Wagner CEO And Unveils New Business Strategy 10/19/2005 5:12:13 PM    More...
$100 Million In State-of-the-Art Biotechnology And Semiconductor Equipment Hits The Auction Block 10/19/2005 5:12:02 PM    More...
Zyomyx, Inc. Strengthens Biochip Intellectual Property 10/19/2005 5:11:15 PM    More...
12

//-->